Detalhe da pesquisa
1.
An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma.
Blood
; 141(10): 1159-1168, 2023 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150143
2.
Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma.
Int J Clin Oncol
; 27(1): 213-223, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599413
3.
Sapropterin for phenylketonuria: A Japanese post-marketing surveillance study.
Pediatr Int
; 64(1): e14939, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331785
4.
Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study.
Cancer Sci
; 112(6): 2361-2370, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686772
5.
A Dose-Finding Method Based on Multiple Dosing in Two-Agent Combination Phase I Trials.
J Biopharm Stat
; 25(5): 1065-76, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25369852
6.
Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia.
Int J Hematol
; 117(1): 68-77, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36258088
7.
A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis.
Int J Hematol
; 117(3): 409-420, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399286
8.
The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas.
Neuro Oncol
; 25(2): 326-336, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35722822
9.
Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 22(2): 134-141, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33518480
10.
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients with advanced solid tumors.
J Immunother Cancer
; 7(1): 219, 2019 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31412935
11.
A randomized, double-blind study of hydromorphone hydrochloride extended-release tablets versus oxycodone hydrochloride extended-release tablets for cancer pain: efficacy and safety in Japanese cancer patients (EXHEAL: a Phase III study of EXtended-release HydromorphonE for cAncer pain reLief).
J Pain Res
; 10: 1953-1962, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28860850